N/A
N=12
Erectile Rating During the Treatment of Rectal Cancers Localized
Rectal Cancer Stage I
Bottom Line
View on ClinicalTrials.gov: NCT01843218 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer — 0 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Evaluation of erectile dysfunction (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Male
- Sponsor
- Institut Bergonié
- Primary completion
- Dec 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Proportion of Patients With Erectile Dysfunction Induced by Medical and Surgical Treatment of Rectal Cancer |
— | — |
| SECONDARY Quality of Nocturnal Erections |
3; 2; 1; 0 | — |
Summary
Sexual dysfunction is a common side effect of medical and surgical treatments for rectal cancer. It can manifest as ejaculation disorders or erectile dysfunction. Due to the modesty of both patients and doctors, these disorders are poorly understood and probably underestimated at present. Aim : Objectively assess the presence of erectile dysfunction induced by medical and surgical treatment of rectal cancer three months after surgery. These objective data will be obtained using the RIGISCAN® PLUS system coupled with polysomnographic recording.
Eligibility Criteria
Inclusion Criteria
- Male patient.
- Age greater than 18 years.
- Neoplastic rectal stage ≤ T3.
- Patient sexually active before diagnosis.
- Laparoscopic surgery.
- Medico-surgical institute Bergonié.
- Patient information and consent for participation in the study.
Exclusion Criteria
- Patients already treated for erectile dysfunction.
- Absence of sexual activity before diagnosis.
- Presence of secondary lesions at diagnosis (M +).
- Classified T4 tumor preoperatively.
- Surgery by laparotomy.
- History of pelvic cancer surgery prostate or bladder.
- History of pelvic radiotherapy (outside of the current process).
- History of prostate or bladder neoplasia known.
- Other neoplastic known.
- Patient for psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study, patient deprived of liberty or under guardianship.
Data sourced from ClinicalTrials.gov (NCT01843218). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.